EPB-002

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameEPB-002

Drug Alias NameEPB-002

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesElpiscience (Shanghai) Biopharma Ltd

China Registration ClassN/A

Develop Information

Active CompaniesElpiscience (Shanghai) Biopharma Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumoursUrinary Bladder NeoplasmsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A